Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1

Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 is a medication belonging to the class of PCSK9 inhibitors. Some common side effects of Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 include injection site reactions, flu-like symptoms, and muscle pain. Patients should be advised that this medication may lower their LDL cholesterol levels significantly and require ongoing monitoring and compliance with therapy.

Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 is administered by subcutaneous injection and can be given by a healthcare professional or self-administered by the patient.

The recommended dosage range for Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 is 140 mg administered subcutaneously once every two weeks.

2 years

Store in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze.

• Injection site reactions
• Flu-like symptoms
• Muscle pain

Contraindications of Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1: Hypersensitivity to evolocumab or any component of the formulation

There are no known drug or food interactions with Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1.

• Follow the recommended dosing schedule
• Keep track of your cholesterol levels with regular monitoring
• Report any new or worsening symptoms to your healthcare provider

1. Can I self-administer Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 injections?
2. Yes, Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 can be self-administered after proper training by a healthcare professional.
3. Are there any dietary restrictions while taking Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1?
4. No, there are no specific dietary restrictions associated with taking Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1.
5. How long does it take for Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1 to start lowering cholesterol levels?
6. Some patients may see a decrease in LDL cholesterol levels within 4 weeks of starting treatment with Repatha Evolocumab 140mg/ml Solution for Injection 1ml x1.